Olatoyosi Odenike to Tumor Suppressor Protein p53
This is a "connection" page, showing publications Olatoyosi Odenike has written about Tumor Suppressor Protein p53.
Connection Strength
0.090
-
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates. Blood Adv. 2023 06 13; 7(11):2360-2363.
Score: 0.046
-
Eprenetapopt combined with venetoclax and azacitidine in TP53-mutated acute myeloid leukaemia: a phase 1, dose-finding and expansion study. Lancet Haematol. 2023 Apr; 10(4):e272-e283.
Score: 0.045